You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 16, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Daniel B Rubin1,2, Ayush Batra3, Ivana Vodopivec2
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Autoimmune neurological diseases in the intensive care unit (ICU) require prompt management despite diagnostic challenges. Focusing on underlying immune mechanisms, rather than specific syndromes, guides effective, early treatment for these critical conditions.
26:48Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: